Goeroptics Showcases Industry-Leading 50° FoV SiC Waveguide and XR Optical Innovations at SPIE

Goeroptics Showcases Industry-Leading 50° FoV SiC Waveguide and XR Optical Innovations at SPIE

SAN FRANCISCO, Jan. 23, 2026 /PRNewswire/ -- Goeroptics, a world's leading AR&MR solution provider, unveiled a suite of advanced XR optical solutions at SPIE AR|VR|MR 2026. The company debut its latest AR flagship product, the F50Se — a 50° FoV...

Beko's Smart Living Index finds Economic Pressure Drives Surge in Sustainable Living

Beko's Smart Living Index finds Economic Pressure Drives Surge in Sustainable Living

ISTANBUL, Jan. 22, 2026 /PRNewswire/ -- Beko, the leading global home appliance company, today unveiled its proprietary Smart Living Index (SLI). The study revealed that financial pressures are now the biggest driver of adoption of sustainable...

Envision Energy Connects First AI Wind Turbine Prototype for Fortescue, Unlocking Australia's Renewable Future

Envision Energy Connects First AI Wind Turbine Prototype for Fortescue, Unlocking Australia's Renewable Future

SHANGHAI, Jan. 22, 2026 /PRNewswire/ -- Envision Energy, a global leader in green technology, has successfully grid-connected the first AI wind turbine prototype for its inaugural project in Australia, supporting Fortescue's Nullagine Wind Project...

Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30

Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30

Positioning Telangana among the world's top five life sciences clusters by 2030 Targets USD 25 billion in investments Shifts focus from scale-led manufacturing to innovation-driven, value creation DAVOS, Switzerland, Jan. 22, 2026 /PRNewswire/ --...

Futu Trustee Launches Groundbreaking "Futu Pension Family Trust" with a Minimum Entry Threshold of HK$3 Million

Futu Trustee Launches Groundbreaking "Futu Pension Family Trust" with a Minimum Entry Threshold of HK$3 Million

HONG KONG, Jan. 21, 2026 /PRNewswire/ -- Futu Trustee Limited, a subsidiary of Futu Holdings Limited (Nasdaq: FUTU), officially unveiled the Futu Pension Family Trust on January 9, 2026, during a concurrent session at the "2025 Hong Kong Wealth...

NYSE Content Advisory: Pre-Market Update + NYSE Creates Tokenized Securities Platform for 24/7 Trading

NYSE Content Advisory: Pre-Market Update + NYSE Creates Tokenized Securities Platform for 24/7 Trading

NEW YORK, Jan. 20, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content...

Hugel accelerates global value creation with U.S.-led growth strategy

Hugel accelerates global value creation with U.S.-led growth strategy

- President and Global CEO Carrie Strom outlines mid-term growth strategy including global vision, U.S. channel strategy, and portfolio expansion - Hugel targets KRW900 billion in total net sales and 30% of sales from U.S. by 2028 SAN FRANCISCO,...

10 Years Since AlphaGo, Code Name: BlueSpot Disclosed Ahead of Handicap-Match Events

10 Years Since AlphaGo, Code Name: BlueSpot Disclosed Ahead of Handicap-Match Events

Code Name: B lueSpot , a Go AI, is disclosed ahead of the handicap - match events in the 10th-anniversary year of the historic AlphaGo–Lee Sedol match. NEW YORK, Jan. 15, 2026 /PRNewswire/ -- Issued by Code Name: BlueSpot Operations BlueSpot’s...

Envision Launches Dubhe, Shaping the AI Energy System with the World's First Energy Foundation Model

Envision Launches Dubhe, Shaping the AI Energy System with the World's First Energy Foundation Model

Envision doubles down on the renewable energy system with its launch of Dubhe, an energy foundation model shaping the AI energy system. ABU DHABI, UAE, Jan. 15, 2026 /PRNewswire/ -- Envision, the global leader in green technology, today announced...

Hyundai Bioscience Confirms Entry into U.S. FDA Phase 2 Trials for Broad-Spectrum Antiviral 'XAFTY' Following 2026 Biotech Showcase Consensus

Hyundai Bioscience Confirms Entry into U.S. FDA Phase 2 Trials for Broad-Spectrum Antiviral 'XAFTY' Following 2026 Biotech Showcase Consensus

- UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war." - Announces "One Drug, Two Tracks" strategy: Targeting Dengue in Vietnam and Respiratory Viruses (Flu, COVID, RSV) in the U.S. with the...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 56
  • menu
    menu